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Abstract 
Background: Chronic venous disease (CVD) is a well-defined and known disorder which impact on related-health 
quality of life (QoL). The Chronic Venous Insufficiency Quality of Life Questionnaire (CIVIQ) is a disease-specific instru-
ment to measure the impact of chronic venous insufficiency on patients’ lives. The purpose of this study is to cross-
culturally adapted the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) for Turkish-speaking patients 
and determine the psychometric properties of reliability, validity and factor structure in a Turkish population with CVD.
Methods: The CIVIQ-20 was translated into Turkish and culturally adapted using a double forward–backward proto-
col according to established guidelines. Individuals (n = 140) with venous diseases completed the CIVIQ-20, Venous 
Insufficiency Epidemiological and Economic Study (VEINES-QoL/Sym) and Nottingham Health Profile (NHP) question-
naires at baseline and 1 month later.
Results: Cronbach’s α value was 0.93. Test–retest reliability was determined as moderate (ICC2:1 = 0.80). There was 
a significant correlation between CIVIQ-Tk and Nottingham and VEINES-QoL total scores (Nottingham 1: r = 0.770; 
p < 0.00, Nottingham 2: r = 0.7000; p < 0) (VEINES-QoL: r = −0.574; p < 0.00, VEINES-QoL 2: −0.592, p: 0.00). The 
measurement error were calculated from SEM and MDC90. The SEM was 2.63 and the MDC90 was 5.79. Exploratory fac-
tor analysis demonstrated a three factor structure that explained 56.32 % of total variance.
Conclusion: The CVIQ-20 Turkish is a reliable and valid instrument for Turkish speaking patients with chronic venous 
insufficiency.
© 2016 Özdemir et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
Chronic venous insufficiency (CVI) is defined as a very 
common medical condition that is related to the venous 
system at the lower extremities involving various pathol-
ogies and subjective symptoms such as pains, cramps, 
irritability in legs, edema, itchiness and skin changes 
(Gulati 2008; Bergan et al. 2006). It is a common disease 
and in the Western countries approximately 62.1  % of 
females and 49.1 % females are affected by venous symp-
toms (Pannier-Fischer and Rabe 2003). About half of the 
general adult population shows the signs of CVI while 
about a quarter of them have lower-extremity varicose 
veins (Evans et  al. 1999). In Turkey, however, the CVI 
condition is reported to affect 20–25  % of women and 
10–15 % of men (Akbulut et al. 2009).
Due to the appearance of varicose veins, CVI symp-
toms and complications, the CVI patients may have 
significant levels of health-related quality of life impair-
ment (HRQoL) (Launois et  al. 1996). The studies show 
that there is a rapid deterioration in quality of life (QoL) 
in persons with venous disease (Kurz et al. 2001; Chiesa 
et  al. 2007). Measurement of QoL that enables a better 
understanding of the effects of the disease is significant 
in terms of evaluating the disease (Garratt et  al. 1993). 
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Although the venous diseases have high prevalence rates, 
they have not been sufficiently studied up until now due 
to the limited number of studies conducted on measuring 
the quality of life (Smith et al. 2000; Kaplan et al. 2003). 
Disease-specific and general quality of life scales have 
been developed to evaluate these cases. Today, numer-
ous proven result measures are being used and they are 
divided into generic and disease-specific QoL tools. 
While general quality-of-life scales can be used in general 
evaluation they fail to meet the CVI-specific conditions. 
In the treatment evaluation, however, care effects and 
disease related effect determination as well as the quality-
of-life scales have been proven to be more effective. It is 
recommended that the generic and disease-specific QoL 
instruments are combined in order to integrate the defi-
ciencies of the generic tools (Lamping et al. 2003; Kahn 
et al. 2004).
36-Item Short Form Health Survey (SF-36) is a com-
monly-used and recognized generic quality-of-life tool. 
The Nottingham Health Profile (NHP) is another generic 
tool which was developed to be applied in various con-
ditions. Aberdeen Varicose Vein Questionnaire (AVVQ), 
the Chronic Venous Insufficiency Quality of Life Ques-
tionnaire (CIVIQ) and the Venous Insufficiency Epide-
miological and Economic Study (VEINES-QoL/Sym) 
questionnaire are the most frequently used disease-spe-
cific tools for varicose veins and CVI (Vasquez and Mun-
schauer 2008). In Turkey, only the VEINES quality-of-life 
questionnaire is used to measure the QoL in patients who 
show the symptoms of CVI.
Launois et  al. developed the CIVIQ in 1996 (Lau-
nois et  al. 1996). It has been established that this 
disease-specific questionnaire is valid and highly 
reproducible with great internal coordination and high 
responsiveness rate. It has also been established that it 
is a precious tool in both clinical practice and trials for 
evaluating improvement in patients’ HRQoL (Lozano 
and Launois 2002). The source questionnaire for 
CIVIQ-20 was confirmed in French. Although there are 
Spanish, Dutch and Greek versions of the test available, 
it has not been translated into other languages (Launois 
et al. 2013).
In order to measure the QoL in patients with CVI 
symptoms in Turkey, only the VEINES quality-of-life 
questionnaire is used. The present study is planned to 
establish the reliability, validity and responsiveness of 
the Turkish version of the CIVIQ in CVI patients. Thus, 
the present study aims to adapt the VEINES-QoL cross-
culturally for Turkish-speaking patients and to define 
the clinical characteristics of reliability, criterion validity, 
internal consistency, measurement mistakes and factor 
structure in patients with Chronic Venous Disease.
Methods
Study subjects
All the consecutive patients who consulted the depart-
ments of vascular surgery of the Abant Izzet Baysal Uni-
versity for varicose veins were asked to participate in this 
study. Patients aged 18 years old who had CVI in CEAP C 
stages C3–C6 and who had the ability to fill in two quality 
of life questionnaires were included in the study. Patients 
who had no reflux during venous ultrasound examination 
were excluded from the study. The study was approved by 
the Non-Interventional Clinical Researches Ethical Com-
mittee of Abant Izzet Baysal University. Informed con-
sent forms were obtained from all individual participants 
included in the study.
Procedure
165 patients with CVI were found eligible and invited to 
participate in this study. Before their outpatient appoint-
ment, all patients were asked to fill out both of the dis-
ease-specific QoL instruments, the VEINES-QoL and 
CIVIQ-20 and in addition one general QoL tool, the 
NHP. 140 patients received generic and disease specific 
HRQoL (CIVIQ-1), and were asked to fill it out in com-
plete self-administration. After a period of 1 month, the 
patients were asked to fill out the tests for test–retest reli-
ability, 120 of whom returned the CIVIQ-2. The same 
physiotherapist collected all tests.
Questionnaire
CIVIQ-20 is a QoL survey that contains 20 questions 
and is specific for CVI, encompassing four QoL domains: 
physical (items 5, 6, 7 and 9), psychological (items 12, 20) 
and social impairment (items 8, 10 and 11) and the sever-
ity of pain (items 1, 4). There is a 5-point answer rating in 
each question, according to which higher scores indicate 
more severe impairment. There is a score varying from 0 
to 100 in the CIVIQ-20 where the higher scores indicate 
better QoL (Launois et al. 1996).
VEINES-QoL/Sym measures the impact of CVI on 
symptoms and quality of life (QoL) from the patient’s per-
spective. The validity and reliability of the Turkish version 
of the VEINES-QoL/Sym was performed by Kutlu et  al. 
(2011). The 26 items and 2 dimensions of the VEINES-
QoL/Sym measure the impact of CVI on symptoms and 
QoL from the patient’s perspective. The first 10 cover the 
symptoms (fullness of lower extremities, pain, swelling, 
night cramps, heat/burning sensation, restless legs, itch-
ing, tingling/stinging sensation, and throbbing) in 5 differ-
ent frequencies (always, a few times a week, once a week, 
once in a few weeks, and never). Limitations in daily activ-
ities (9 items), time of day of greatest intensity (1 item), 
and change over the past year (1 item), and psychological 
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impact (5 items) are covered by the QoL scale with 2- to 
7-point response scales of intensity, frequency, or agree-
ment. Venous symptoms were assessed based on the 
symptoms that are part of the VEINES-QoL/Sym. Each 
item score varies between 0 and 6, according to which 
high scores indicate better outcomes in VEINES-QoL and 
VEINES-Sym scales (Kutlu et al. 2011).
Nottingham Health Profile (NHP) is a generic health 
instrument that is used for the measuring the quality of 
life. It contains 6 subscales and 38 questions with each 
assigned a weighted value; the sum of all weighted values 
in a given item adds up to 100. The 6 subscales include the 
energy level (EL) subscale containing 3 questions, pain 
(P) subscale contains 8 question, emotional reaction (ER) 
subscale containing 9 questions, sleep (S) subscale, con-
taining 5 question, social isolation (SI) subscale containing 
5 questions, and physical abilities (PA) subscale contain-
ing 8 questions. To obtain a final score in each dimension, 
and to overcome the issue of having a different number of 
items in some of the dimensions, each sum was multiplied 
by 100 and divided by the number of items in the dimen-
sion. Possible scores ranged from 0 (all answers of “no” in 
the dimension, denoting absence of distress) to 100 (all 
answers of “yes”, denoting maximal distress). High scores 
indicate worse outcomes. The reliability and validity of the 
Turkish version of the NHP has been demonstrated in a 
previous study (Kücükdeveci et al. 2000).
Translation and cross‑cultural adaptation
By means of the suggested double forward backward 
translation, the CIVIQ questionnaire was translated 
into Turkish (Launois et al. 2013). The questions and the 
answer choices of the English version were translated 
separately by two Turkish native-language translators and 
thereby the CIVIQ was adapted into the Turkish context. 
The translators were from a registered translation office 
and a physiotherapist for better idiomatic and conceptual 
(rather than literal) equivalence and reliability. Thus, the 
words and language structure were elementary. The two 
translators compared and discussed the obtained sepa-
rate forward translations. The purpose of the stage was 
to determine and solve the insufficient terms and expres-
sions of the scale which was translated into the target 
language separately by bringing the experts in the jury 
together. At the end of this stage, the questionnaire that 
was translated into Turkish was put into the final form. 
The two English native-language speakers back trans-
lated blindly and separately. For contradictions, the final 
forms and the original version were compared and a 
pilot agreement form was completed. In order to obtain 
a qualitative testing of legibility and understanding, the 
Turkish CIVIQ was given to 20 patients who had venous 
disease of the lower limbs. These persons were asked 
whether they had difficulty in understanding the ques-
tionnaire and whether there were complicated expres-
sions. Because of this qualitative questionnaire proved 
no difficulty with the Turkish CIVIQ, all cultural adap-
tation procedures were completed and the scale was put 
into the final form after the corrections were made. It was 
subsequently administered to the study population to 
collect data for psychometric analysis.
Statistics
Descriptive analyses were applied to calculate means 
and standard deviations of the demographic variables. 
Distribution and normality were determined by the one-
sample Kolmogorov–Smirnov tests (significance >0.05). 
Construct validity and factor structure were determined 
from maximum likelihood extraction (MLE) with the 
a priori extraction requirements being satisfaction of 
three criteria: scree plot inflection, Eigenvalue >1.0 and 
variance >10 % (de Vet et al. 2011; Costello and Osborne 
2005). The recommended minimum ratio of ten partic-
ipants-per-item was satisfied (Cronbach 1951). Factor 
structure was assessed using exploratory factor analysis 
(EFA) with MLE and Varimax rotation. The three a priori 
criteria for inclusion of the extracted factors were: Eigen-
values >1, accounting for >10 % of variance and visually 
determined on the scree plot (de Vet et  al. 2005). The 
internal consistency was determined from Cronbach’s α 
coefficient (Stratford 2004). Criterion validity was deter-
mined through the concurrent use of all QoL instrument. 
The Pearson’s r correlation coefficient used the criteria of 
poor (r < 0.49), fair (r = 0.50–0.74) and strong (r > 0.75) 
(Fabrigar et al. 1999).
Reliability was performed using the Intraclass Correla-
tion Coefficient Type 2:1 (ICC2:1) test–retest methodol-
ogy in the full sample recorded at baseline and 2–4 weeks 
following a period of no treatment. The sensitivity or 
error score was determined from the MDC90 analysis 
that was performed as described by Stratford (Stratford 
2004). The standard error of the measurement (SEM) 
was calculated using the formula: SEM  =  s√(1  −  r), 
where s  =  standard deviation (SD) of time 1 and time 
2, r = the reliability coefficient for the test and Pearson’s 
correlation coefficient between test and retest values. 
Thereafter the MDC90 was calculated using the formula: 
MDC90 = SEM × √2 × 1.65.
All statistical analyses were conducted using the Statis-




140 patients with CVI was participated in the study. The 
average age of participants 52.3  ±  13.40  years. The 101 
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patients were women; 39 were men. The demographic 
characteristics of subjects were shown in Tables 1 and 2. 
The variables were normally distributed (p > 0.05). Double 
forward backward translation of the CIVIQ was conducted 
without difficulty. Cognitive debriefing interviews were 
conducted with 5 patients for considering if the question-
naire is understandable and culturally relevant. As a result 
of cognitive debriefing interviews all patients who partici-
pated to the interviews reflected that the questionnaire is 
easily understandable, readable and culturally relevant.
Internal consistency, test–retest reliability, criterion 
validity and error score
Cronbach’s α value was 0.93 which indicate a high inter-
nal consistency of CIVIQ Turkish. Test–retest reliability 
was determined as moderate (ICC2:1 = 0.80). There was 
a significant correlation between CIVIQ Turkish, Not-
tingham and VEINES-QoL total scores (Nottingham 
1: r = 0.770; p < 0.00, Nottingham 2: r = 0.7000; p < 0) 
(VEINES-QoL r  =  −0.574; p  <  0.00, VEINES-QoL 2: 
−0.592, p: 0.00). The value of this correlation means a 
strong criterion validity. The measurement error were 
calculated from SEM and MDC90. The SEM was 2.63 and 
the MDC90 was 5.79.
Factor analysis
The correlation matrix for the CIVIQ Turkish was deter-
mined as suitable from the Kaiser–Meyer–Olkin values 
(0.66) and the Bartlett’s Test of Sphericity (p  <  0.001). 
This indicated that the correlation matrix was unlikely 
to be an identity matrix and was therefore suitable for 
MLE. The scree plot (see Fig. 1) indicated a three-factor 
solution. The factor analysis revealed a satisfactory per-
centage of total variance explained by the three factor at 
56.32 %.
The factor analysis revealed four factors with Eigenval-
ues >1. Four factors accounted for >10 % variance and the 
scree plot occurred at the third point (Fig.  1). The item 
loading for the three-factor solution for the MLE method 
and average score for each item are shown in Table 3.
Discussion
The CIVIQ is used in clinics in Turkey with simply 
translated versions (without formal methodology). 
However, there is no study on culturally adaptation and 
linguistic validation of CIVIQ in Turkish speaking popu-
lation. Therefore, we decided to do a study that aims to 
adapt the CIVIQ cross-culturally for Turkish-speaking 
patients. The procedure of translation and cross-cultural 
adaptation were easily conducted with the considera-
tion of international guidelines. The procedure is also 
similar with methodology of other studies that adapt 
the patient reported questionnaires in Turkey (Tuy-
gun et al. 2012). The face validity was observed through 
the cognitive debriefing interviews and the translation 
process The Turkish version of CIVIQ questionnaire is 
self-administered, simply completed and short lasting 
according to cognitive debriefing interviews. There was 
no need to extract any item, add a new item or modify 
any item. Launois et al. reviewed the all linguistic valida-
tion studies of CIVIQ in different countries. According 
to Launois study there were some linguistic or culturally 
adaptations in items in some countries (Launois et  al. 
2013).
The Cronbach’s α coefficient at 0.93 showed strong 
internal consistency. This result similar with Dutch and 
Greek versions (>0.90). That seems the questionnaire is 
strongly reliable because the Cronbach’s α value >0.70 
but a little excessive similar with Dutch and Greek ver-
sions. The test–retest reliability (r = 0.80) was high and 
comparable with the findings of Dutch version (ICC2:1: 
0.86) (Biemans et al. 2011; Erevnidou et al. 2004).
The factor structure was shown as a 3-factor structure 
(physical, pain, psychological) under the a priori criteria 
similar with Dutch version. Differently four quality of life 
dimensions (Physical, psychological, social, pain) used in 
Table 1 Demographic and clinical features of the patients
X ± SD
Age (years) 52.3 ± 13.4
Height (m) 1.62 ± 12.6
Weight (kg) 81.1 ± 11.6
BMI (kg/m2) 30.2 ± 4.3




 Woman 101 72.1
 Man 39 27.9
Educational status
 Illiterate 2 1.4
 Primary level 72 51.4
 High school level 45 32.1
 University 21 15
Occupation
 Housewife 65 46.4
 Worker 35 25
 Retired 40 28.6
CEAP
 C3 119 85
 C4 17 12.1
 C5–C6 4 2.9
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original CIVIQ-20. The extracted first factor has a satis-
factory percentage of total variance explained by the one 
factor at 30.6  %. While the Dutch version’s extracted of 
the first factor accounted for 43.7 % of the variability of 
the CIVIQ. There is no item that loads under 0.20 but in 
Greek version there is one item loaded <0.20.
Strengths of the study included the standardized 
methods employed for all psychometric procedures 
and the cross-cultural adaptation process. Impor-
tantly, this is the second study to adapt a CVI ques-
tionnaire to the Turkish language for general use. 
The limitations were the lack of longitudinal data 
regarding other psychometric properties including 
responsiveness.
Conclusion
The CIVIQ Turkish demonstrated a 3-factor structure 
and is a reliable and valid instrument. The CIVIQ Turk-
ish in its present form consists of simple and easily 
understood language which may enable it to be used to 
assess chronic venous insufficiency in Turkish speaking 
patients.
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CVI: chronic venous insufficiency; HRQoL: health-related quality of life; SF-36: 
36-Item Short Form Health Survey; NHP: Nottingham Health Profile; AVVQ: 
Fig. 1 Scree plot of the factor analysis
Table 3 Factor analysis loadings of the CIVIQ-20
Items Factors
1 2 3
1. Pain in legs 0.500 0.113 0.535
2. Interferes with work 0.691 0.172 0.247
3. Sleeping poorly 0.257 0.120 0.800
4. To stand for a long time 0.730 0.212 0.156
5. To climb stairs 0.785 −0.008 0.069
6. To crunch/to kneel 0.726 0.243 0.181
7. To walk briskly 0.743 0.067 0.130
8. To travel by car/bus/plane 0.602 0.195 0.237
9. To do the housework 0.813 0.081 0.254
10. Going to parties 0.697 0.138 0.410
11. To perform sports activities 0.751 0.183 0.200
12. Feel on edge 0.275 0.517 0.462
13. Get tired easily 0.601 0.480 0.157
14. Feel like a burden people 0.225 0.437 0.385
15. I feel weaker and stiffer 0.480 0.544 −0.090
16. Embarrassed to show legs 0.008 0.768 0.179
17. Easily irritable 0.031 0.681 0.255
18. Impression of being disabled 0.379 0.681 0.120
19. Difficulty getting up in the morning 0.211 0.210 0.680
20. Do not feel like going out 0.193 0.193 0.140
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Aberdeen Varicose Vein Questionnaire; CIVIQ: Chronic Venous Insufficiency 
Quality of Life Questionnaire; VEINES-QoL: Venous Insufficiency Epidemiologi-
cal and Economic Study; BMI: body mass index; kg: kilogram; m: metre.
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